Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000009436 | SCV000784568 | uncertain significance | Holoprosencephaly 3 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000662212 | SCV000784569 | uncertain significance | Schizencephaly | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000662213 | SCV000784570 | uncertain significance | Microphthalmia, isolated, with coloboma 5 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000662214 | SCV000784571 | uncertain significance | Solitary median maxillary central incisor syndrome | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000662212 | SCV001367474 | uncertain significance | Schizencephaly | 2020-01-29 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Labcorp Genetics |
RCV000009436 | SCV003524407 | uncertain significance | Holoprosencephaly 3 | 2022-09-14 | criteria provided, single submitter | clinical testing | Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on SHH function (PMID: 15292211, 32939873). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SHH protein function. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 383 of the SHH protein (p.Ala383Thr). This variant is present in population databases (rs137853341, gnomAD no frequency). This missense change has been observed in individual(s) with holoprosencephaly (PMID: 9302262). This variant is also known as Ala384Thr. ClinVar contains an entry for this variant (Variation ID: 8886). |
Revvity Omics, |
RCV003137506 | SCV003820001 | uncertain significance | not provided | 2019-12-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000009436 | SCV000029654 | pathogenic | Holoprosencephaly 3 | 1997-10-01 | no assertion criteria provided | literature only | |
Gene |
RCV000009436 | SCV000087133 | pathologic | Holoprosencephaly 3 | 2013-08-29 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |